Fig. 5: Molecular docking results.

Molecular docking results for mosapramine and seven targets, including AKT3 (AKT Serine/Threonine Kinase 3), EGFR (epidermal Growth Factor Receptor), IL6 (interleukin 6), INS (insulin A chain), MAPK1(mitogen-activated protein kinase 1), MAPK3 (mitogen-activated protein kinase 3), PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1).